Skip to main content
. Author manuscript; available in PMC: 2021 Sep 8.
Published in final edited form as: Cell Rep. 2021 Aug 10;36(6):109506. doi: 10.1016/j.celrep.2021.109506

Figure 4. RNF8 is decayed by let-7 miRNA, and RXRα protein is ubiquitinated by RNF8 E3 ubiquitin ligase.

Figure 4.

(A) Predicted let-7 miRNA binding sites in Rnf8 mRNA.

(B–F) Western blot analysis and densitometric quantification of RNF8 protein (B, D, and F) and qRT-PCR of Rnf8 mRNA (C and E) in let7b/c2+/+ and let7b/c2ΔHep (B and C); EGFP and let-7 sponge AAV-transduced (D and E); EGFP and pre-let-7c-1 AAV-transduced (F) livers treated with HFD feeding.

(G) 3′ UTR reporter assays in HepG2 cells transfected with Rnf8 wild-type or mutant 3′ UTR reporter constructs and a let-7c mimic expression vector.

(H and I) Western blot analysis (H) and densitometric quantification (I) of RXRα expression in Rxra- and Rnf8-transfected Hepa-1 cells.

(J and K) Fold change of Rnf8 (J) and Rxra (K) mRNA by qRT-PCR analysis in Rxra- and Rnf8-transfected Hepa-1 cells.

(L) Western blot analysis and the densitometric quantification of RXRα in Rxra- and Rnf8-transfected Hepa-1 cells treated with the proteasome inhibitor MG-132.

(M) Ubiquitination assays for Rxra- and Rnf8-transfected and MG-132-treated Hepa-1 cells. RXRα was immunoprecipitated and polyubiquitin detected by anti-ubiquitin antibody. RXRα expression was confirmed in whole-cell lysate as input.

(N) Scheme of 3-step inhibition for PPARα/RXRα pathway that the current study demonstrates.